A detailed history of Rossmore Private Capital transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Rossmore Private Capital holds 18,854 shares of EW stock, worth $1.41 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
18,854
Previous 19,354 2.58%
Holding current value
$1.41 Million
Previous $1.79 Million 30.39%
% of portfolio
0.15%
Previous 0.24%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$59.7 - $93.78 $29,850 - $46,890
-500 Reduced 2.58%
18,854 $1.24 Million
Q2 2024

Aug 12, 2024

SELL
$84.3 - $94.31 $20,316 - $22,728
-241 Reduced 1.23%
19,354 $1.79 Million
Q1 2024

May 13, 2024

SELL
$72.54 - $95.56 $10,155 - $13,378
-140 Reduced 0.71%
19,595 $1.87 Million
Q4 2023

Feb 07, 2024

SELL
$61.71 - $77.76 $617 - $777
-10 Reduced 0.05%
19,735 $1.5 Million
Q3 2023

Nov 13, 2023

SELL
$69.28 - $93.38 $4,572 - $6,163
-66 Reduced 0.33%
19,745 $1.37 Million
Q1 2023

May 02, 2023

SELL
$74.26 - $84.51 $237,632 - $270,432
-3,200 Reduced 13.91%
19,811 $1.64 Million
Q4 2022

Feb 13, 2023

SELL
$68.3 - $87.44 $683 - $874
-10 Reduced 0.04%
23,011 $1.72 Million
Q4 2021

Feb 07, 2022

SELL
$106.37 - $130.68 $7,445 - $9,147
-70 Reduced 0.3%
23,021 $2.98 Million
Q3 2021

Nov 08, 2021

SELL
$102.91 - $122.75 $26,139 - $31,178
-254 Reduced 1.09%
23,091 $2.61 Million
Q2 2021

Aug 13, 2021

SELL
$83.84 - $104.76 $22,217 - $27,761
-265 Reduced 1.12%
23,345 $2.42 Million
Q4 2020

Feb 10, 2021

SELL
$71.69 - $91.23 $44,304 - $56,380
-618 Reduced 2.55%
23,610 $2.15 Million
Q3 2020

Nov 10, 2020

BUY
$67.19 - $87.44 $1.63 Million - $2.12 Million
24,228 New
24,228 $1.93 Million
Q2 2020

Aug 05, 2020

SELL
$57.54 - $76.95 $327,632 - $438,153
-5,694 Closed
0 $0
Q1 2020

May 07, 2020

BUY
$52.41 - $81.0 $298,422 - $461,214
5,694 New
5,694 $1.07 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Rossmore Private Capital Portfolio

Follow Rossmore Private Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rossmore Private Capital, based on Form 13F filings with the SEC.

News

Stay updated on Rossmore Private Capital with notifications on news.